Dr. Melinda Pauly, MD
Claim this profileChildren's Healthcare of Atlanta
Studies Leukemia
Studies Acute Lymphoblastic Leukemia
10 reported clinical trials
14 drugs studied
Area of expertise
1Leukemia
CD123 positive
Philadelphia chromosome positive
CD22 positive
2Acute Lymphoblastic Leukemia
CD123 positive
Philadelphia chromosome positive
CD22 positive
Affiliated Hospitals
Clinical Trials Melinda Pauly, MD is currently running
Inotuzumab Ozogamicin
for Leukemia and Lymphoma
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with B-lymphoblastic lymphoma or CD22 positive B acute lymphoblastic leukemia that has come back (relapsed) or does not respond to treatment (refractory). Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a toxic agent called ozogamicin. Inotuzumab attaches to CD22 positive cancer cells in a targeted way and delivers ozogamicin to kill them.
Recruiting1 award Phase 210 criteria
Caloric Restriction + Activity
for Acute Lymphoblastic Leukemia
This trial tests if a personalized diet and exercise plan can help older children, adolescents, and young adults with high-risk B-cell Acute Lymphoblastic Leukemia respond better to chemotherapy. The plan aims to reduce body fat, which is linked to treatment resistance, and limit fat gain during chemotherapy.
Recruiting1 award Phase 2
More about Melinda Pauly, MD
Clinical Trial Related7 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Melinda Pauly, MD has experience with
- Matched Targeted Therapy
- Marqibo
- IDEAL2 Intervention
- Tagraxofusp
- Data Collection
- Quality-of-Life Assessment
Breakdown of trials Melinda Pauly, MD has run
Leukemia
Acute Lymphoblastic Leukemia
Lymphoblastic Leukemia-Lymphoma
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Melinda Pauly, MD specialize in?
Melinda Pauly, MD focuses on Leukemia and Acute Lymphoblastic Leukemia. In particular, much of their work with Leukemia has involved CD123 positive patients, or patients who are Philadelphia chromosome positive.
Is Melinda Pauly, MD currently recruiting for clinical trials?
Yes, Melinda Pauly, MD is currently recruiting for 5 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Melinda Pauly, MD has studied deeply?
Yes, Melinda Pauly, MD has studied treatments such as Matched Targeted Therapy, Marqibo, IDEAL2 Intervention.
What is the best way to schedule an appointment with Melinda Pauly, MD?
Apply for one of the trials that Melinda Pauly, MD is conducting.
What is the office address of Melinda Pauly, MD?
The office of Melinda Pauly, MD is located at: Children's Healthcare of Atlanta, Atlanta, Georgia 30322 United States. This is the address for their practice at the Children's Healthcare of Atlanta.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.